134 related articles for article (PubMed ID: 12686851)
21. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
23. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
24. Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH.
Haecker FM; von Schweinitz D; Harms D; Buerger D; Graf N
J Urol; 2003 Sep; 170(3):939-42; discussion 943-4. PubMed ID: 12913746
[TBL] [Abstract][Full Text] [Related]
25. The treatment of Wilms tumor. Results of the National Wilms Tumor Studies.
Green DM; Thomas PR; Shochat S
Hematol Oncol Clin North Am; 1995 Dec; 9(6):1267-74. PubMed ID: 8591964
[TBL] [Abstract][Full Text] [Related]
26. Amplification and expression of EGFR and ERBB2 in Wilms tumor.
Vasei M; Modjtahedi H; Ale-Booyeh O; Mosallaei A; Kajbafzadeh AM; Shahriari M; Ghaderi AA; Soleymanpour H; Kosari F; Moch H; Sauter G
Cancer Genet Cytogenet; 2009 Oct; 194(2):88-95. PubMed ID: 19781441
[TBL] [Abstract][Full Text] [Related]
27. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
28. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
30. Increased microvascular density predicts relapse in Wilms' tumor.
Abramson LP; Grundy PE; Rademaker AW; Helenowski I; Cornwell M; Katzenstein HM; Reynolds M; Arensman RM; Crawford SE
J Pediatr Surg; 2003 Mar; 38(3):325-30; discussion 325-30. PubMed ID: 12632343
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
32. [Renal neoplasms in children].
Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of nephron sparing surgery and simple nephrectomy for unilateral localized Wilms tumor.
Zani A; Schiavetti A; Gambino M; Cozzi DA; Conforti A; Cozzi F
J Urol; 2005 Mar; 173(3):946-8; discussion 948. PubMed ID: 15711346
[TBL] [Abstract][Full Text] [Related]
34. [Bilateral Wilms tumor].
Presedo A; Martínez Ibáñez V; Marqués A; Sánchez de Toledo J; Boix Ochoa J
Cir Pediatr; 1997 Jul; 10(3):108-11. PubMed ID: 9376233
[TBL] [Abstract][Full Text] [Related]
35. National reevaluation of staging in Wilms tumor.
Kullendorff CM; Wiebe T; Hayder S
Eur J Pediatr Surg; 1996 Feb; 6(1):23-4. PubMed ID: 8721173
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors.
el Bahtimi R; Hazen-Martin DJ; Re GG; Willingham MC; Garvin AJ
Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221
[TBL] [Abstract][Full Text] [Related]
37. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of survivin expression in Wilms tumor.
Basta-Jovanovic G; Radojevic-Skodric S; Brasanac D; Djuricic S; Milasin J; Bogdanovic L; Opric D; Savin M; Baralic I; Jovanovic M
J BUON; 2012; 17(1):168-73. PubMed ID: 22517713
[TBL] [Abstract][Full Text] [Related]
40. Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.
Ehrlich PF; Ritchey ML; Hamilton TE; Haase GM; Ou S; Breslow N; Grundy P; Green D; Norkool P; Becker J; Shamberger RC
J Pediatr Surg; 2005 Jan; 40(1):208-12; discussion 212-3. PubMed ID: 15868587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]